Markers of nerve tissue injury in the cerebrospinal fluid in patients with lumbar disc herniation and sciatica

Spine

Volumn 24, Issue 8, 1999, Pages 742-746

  Brisby, Helena ^a   Olmarker, Kjell ^a   Rosengren, Lars ^b   Cederlund, Claes Göran ^a   Rydevik, Björn ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cerebrospinal fluid; Glial fibrillary acidic protein; Intervertebral disc displacement; Nerve compression; Nerve tissue protein; Neurofilament proteins; Phosphopyruvate hydratase; S 100 protein; Sciatica

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN S 100;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; ISCHIALGIA; LUMBAR DISK HERNIA; LUMBAR PUNCTURE; MALE; NERVE INJURY; PRIORITY JOURNAL; PROTEIN DETERMINATION; RADIOIMMUNOASSAY;

ADULT; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INTERVERTEBRAL DISK DISPLACEMENT; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; NEUROFILAMENT PROTEINS; NEUROGLIA; PHOSPHOPYRUVATE HYDRATASE; PROGNOSIS; RADIOIMMUNOASSAY; S100 PROTEINS; SCIATICA; SPINAL NERVE ROOTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033561111     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007632-199904150-00003     Document Type: Article

References (28)

1. Aurell A, Rosengren LE, Olsson J-E, Zbornikova V, Haglid KG. Determination of S-100 and GFA protein concentrations in cerebrospinal fluid after brain infarction. Stroke 1991;22:1254-8.
2. Blennow K, Wallin A, Ekman R. Neuron specific enolase in cerebrospinal fluid: A biochemical marker for neuronal degeneration in dementia disorders? J Neural Trans 1994;8:183-91.
3. Bobechko WP, Hirsch C. Auto-immune response to nucleus pulposus in the rabbit. J Bone Joint Surg [Br] 1965;47B:574-80.
4. Crols R, Saerens J, Noppe M and Lowenthal A. Increased GFAP levels in CSF as a marker of organicity in patients with Alzheimer's disease and other types of irreversible chronic organic brain syndrome. J Neurol 1986;233:157-60.
5. Gertzbein SD, Tile M, Gross A, Falk R. Autoimmunity in degenerative disc disease of the lumbar spine. Orthop Clin North Am 1975;6:1:67-73.
6. Karlsson J-E, Rosengren LH, Haghd KG. Quantitative and qualitative alterations of neuronal and glial intermediate filament in rat nervous system after exposure to 2,5-hexanedione. J Neurochem 1991;57:1437-44.
7. Lamers KJB, van Engelen BGM, Gabreels FJM, Hommes OR, Borm GF, Wevers RA. Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurologic disorders. Acta Neurol Scand 1995:92;247-51.
8. Lasek RJ. Studying the intrinsic determinants of neuronal form and function. In: Lasek RJ and Black MM, eds. Intrinsic Determinations of Neuronal Form and Function. New York: Alan R. Liss, 1-60.
9. Marshall LL, Trethewie ER. Chemical radiculitis. Clin Orthop 1977;129: 61-7.
10. McCarron RF, Wimpee MW, Hudkins P, Laros GS. The inflammatory effect of nucleus pulposus. A possible element in the pathogenesis of low-back pain. Spine 1987;12;760-4.
11. Mokuno K, Kiyosawa K, Sugimura K et al. Prognostic value of cerebrospinal fluid neuron-specific enolase and S-100b protein in Guillain-Barré syndrome. Acta Neurol Scand 1994:89;27-30.
12. Noppe M, Crols R, Andries D, Lowenthal A. Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology. Clin Chim Acta 1986;155:143-50.
13. Nygaard O, Langbakk B, Rommer. Age- and sex-related changes of S-100 protein concentrations in cerebrospinal fluid and serum in patients with no previous history of neurologic disorder. Clin Chem 1997;43:541-3.
14. Olmarker K, Rydevik B, Nordborg C. Autologous nucleus pulposus induces neurophysiologic and histologic changes in porcine cauda equina nerve roots. Spine 1993;18:1425-32.
15. Olmarker K, Blomquist MS, Strömberg MS, Nannmark U, Thomsen P, Rydevik B. Inflammatogenic properties of nucleus pulposus. Spine 1995;6:665-9.
16. Olmarker K, Nordborg C, Larsson K, Rydevik B. Ultrasrructural changes in spinal nerve roots induced by autologous nucleus pulposus. Spine 1996;21: 411-4.
17. Olmarker K, Brisby H, Yabuki S, Nordborg C, Rydevik B. The effects of normal, frozen and hyaluronidase digested nucleus pulposus on nerve root structure and function. Spine 1997;24:471-5.
18. Rosengren L, Ahlse'n G, Belfrage M, Gillberg C, Haglid KG, Hamherger A. A sensitive ELISA for glial fibrillary acidic protein: application in CSF of children. J Neurosci Methods 1992;44:113-9.
19. Rosengren LE, Wikkelso C, Hagberg L. A sensitive ELISA for glial fibrillary acidic protein: Application in CSF in adults. J Neurosci Methods 1994;51;197-204.
20. Rosengren LE, Lycke J, Andersen O. Glial fibrillary acidic protein in CSF of multiple sclerosis patients: Relation to neurologic deficit. J Neurol Sci 1995;133: 61-5.
21. Rosengren LE, Karlsson J - E, Karlsson J-O, Persson L, Wikkelso C. Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem 1996;67:2017-20.
22. Sindic CJM, Chalon MP, Cambiasco CL, Laterre EC, Masson PL. Assessment of damage to the central nervous system by determination of S-100 protein in cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1982;45:1130-5.
23. Skouen JS, Larsen JL, Vollset SE. Cerebrospinal fluid proteins as indicators of nerve root compression in patients with sciatica caused by disc herniation. Spine 1993;18:72-9.
24. Skouen JS, Larsen JL, Vollset E, Gronning M. Elevated cerebrospinal fluid proteins in sciatica caused by disc herniation. Eur Spine J 1994;3:107-11.
25. Skouen JS, Larsen JL, Vollset SE. Cerebrospinal fluid protein concentration related to clinical findings in patients with sciatica caused by disc herniation. J Spinal Disord 1994;7:12-8.
26. Wallin A, Blennow K, Rosengren LE. Glial fibrillary acidic protein in the cerebrospinal fluid of patients with dementia. Dementia 1996;7:267-72.
27. Watson D. Regional variation in the abundance of axonal cytoskeletal proteins. J Neurosci Res 1991;30:226-31.
28. Zomzely-Neurath CE. The nervous system specific S-100 protein. In: Lajtha A, ed. Handbook of Neurochemistry. Vol 5. New York: Plenum Press, 1983:65-100.